Patterns of Association
Expert and novice. Physician and patient. The presumed dichotomy between those deemed experts or knowledgeable, compared to those deemed novices...
Ode to Civics
In honor of National Poetry Month, we share a prose-poem dedicated to a region of America that has been decimated...
Gain of Function in Wuhan
The World Health Organization released its initial report on the origins of the COVID-19 pandemic - and in the process,...
COVID’s K-Shaped Recovery
While most project an optimistic outlook for economic recovery post-pandemic, we find it to be fundamentally disjointed, revealing structural economic...
Healthcare Innovation is Evolutionary
The pandemic may have put an end to many things, but it only accelerated early stage funding into healthcare startups....
Mens Rea & Dr. Gokal
A Houston physician finds himself facing the ire of the law after he administered vaccines to acquaintances not scheduled to...
The Importance of Credibility
Rule of law demands equal treatment under the law. Yet when physicians are accused of crimes, rule of law often...
When Economy Becomes Biology
Under the new COVID-19 relief package, the federal government provides long overdue support for those suffering in the midst of...
What Happened to COVID-19 Testing?
In recent weeks COVID-19 testing has reduced significantly, which many attribute to the rise in vaccinations. But positivity rates are...
Patient Cyber Narratives
Healthcare will become more decentralized and populist post-pandemic. With patients relying upon digital and internet-based tools to seek medical care...
Taxing Healthcare Behavior
If we have learned anything from the pandemic, it is that healthcare is linked to all aspects of society, and...
The Pandemic May End Soon – That’s the Problem
With the pandemic ending, we are beginning to predict the future of healthcare and society. But the future never follows...
Semaglutide and the Expansion Problem: When One Trial Becomes a Platform
Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...
Read more